A clinically silent, but severe, duodenal complication of duodopa infusion: Figure 1
- 27 April 2012
- journal article
- postscript
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 83 (6), 668-670
- https://doi.org/10.1136/jnnp-2011-301984
Abstract
Duodenal levodopa/carbidopa gel infusion (Duodopa) is an efficacious therapeutic strategy for motor and non-motor symptoms in advanced Parkinson's disease (PD).1–3 Technical issues like kinking, knotting or obstruction of the tube are frequent, as well as complications due to the procedure, such as buried bumper syndrome, local infection and dislocation of the tube in the stomach (57%–69% of the patients), but they are seldom associated with severe adverse effects.1 3 4 In most cases, they are generally easy to suspect due to the immediate lack of therapeutic efficacy or malfunction of the infusion pump. We describe a rare and very serious gut complication associated with the device, which is difficult to recognise because of the persistence of clinical benefit on motor signs. A 72-year-old man with a medical history of hypertension and chronic obstructive pulmonary disease, and with a …This publication has 5 references indexed in Scilit:
- Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's diseaseMovement Disorders, 2011
- Asparagus and jejunal-through-PEG: An unhappy encounter in intrajejunal levodopa infusion therapyParkinsonism & Related Disorders, 2011
- Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's diseaseMovement Disorders, 2009
- Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of lifeMovement Disorders, 2009
- Enteral Levodopa/Carbidopa Infusion in Advanced Parkinson DiseaseClinical Neuropharmacology, 2008